Rubinstein Lab OSUCCC – James

The Rubinstein Lab is focused on developing immune-based strategies for the treatment of cancer and human disease.

Jack Rubinstein, MD

James R Latronica, DO University of Pittsburgh Department of Psychiatry

Collaborators — The Paulos Laboratory

BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. - Abstract - Europe PMC

Clinical Trials Office

Shared Resources OSUCCC – James

Research @ UPIKE

Biochemistry, University of Toronto – John L. Rubinstein

Email - The Pelotonia Institute for Immuno-Oncology Winter 2020 Newsletter - Ohio State University Medical Center

Recent recruits Frontiers Spring 2021

Aug2013 GeT-RM project and genome browser

Shared Resources OSUCCC – James

Email - The Pelotonia Institute for Immuno-Oncology Spring 2020 Newsletter - Ohio State University Comprehensive Cancer Center

The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how? - Gynecologic Oncology

MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer